• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

刺激造血作为输血的替代方法。

Stimulation of hematopoiesis as an alternative to transfusion.

作者信息

Dudrick S J, O'Donnell J J, Matheny R G, Unkel S P, Raleigh D P

出版信息

South Med J. 1986 Jun;79(6):669-73. doi: 10.1097/00007611-198606000-00005.

DOI:10.1097/00007611-198606000-00005
PMID:3086983
Abstract

Optimal parenteral nutritional support, provided concomitantly with extraordinarily large replacement doses of intravenous iron dextran can be safe, effective, and life-saving for severely anemic patients who cannot or will not accept erythrocyte transfusion. Five patients who had sustained massive acute blood loss and two who had severe chronic anemia received as much as 140 ml of iron dextran intravenously. The average initial hemoglobin value in the patients with acute blood loss was 4.7 gm/dl (range 2.6 to 8.4 gm/dl), increasing to an average of 9.8 gm/dl (range 7.5 to 12.8) in 23.4 days (range 17 to 30 days), a 166% increase. The average initial hemoglobin value in the patients with chronic anemia was 3.7 gm/dl, increasing to 10.5 gm/dl over an average period of 121 days, a 182% increase. Total abdominal colectomy, pyloroplasty with truncal vagotomy, and highly selective vagotomy were accomplished without complications in four of the patients. There were no adverse reactions to the therapeutic regimen, and all patients were discharged in good condition.

摘要

对于那些不能或不愿接受红细胞输血的严重贫血患者,在给予超大剂量静脉注射右旋糖酐铁的同时提供最佳肠外营养支持是安全、有效的,甚至可能挽救生命。五名遭受大量急性失血的患者和两名患有严重慢性贫血的患者静脉注射了多达140毫升的右旋糖酐铁。急性失血患者的平均初始血红蛋白值为4.7克/分升(范围为2.6至8.4克/分升),在23.4天(范围为17至30天)内平均升至9.8克/分升(范围为7.5至12.8),增长了166%。慢性贫血患者的平均初始血红蛋白值为3.7克/分升,在平均121天内升至10.5克/分升,增长了182%。四名患者成功进行了全腹结肠切除术、胃幽门成形术加迷走神经干切断术以及高选择性迷走神经切断术,且无并发症。该治疗方案没有不良反应,所有患者均康复出院。

相似文献

1
Stimulation of hematopoiesis as an alternative to transfusion.刺激造血作为输血的替代方法。
South Med J. 1986 Jun;79(6):669-73. doi: 10.1097/00007611-198606000-00005.
2
Rapid restoration of red blood cell mass in severely anemic surgical patients who refuse transfusion.拒绝输血的严重贫血外科患者红细胞量的快速恢复。
Arch Surg. 1985 Jun;120(6):721-7. doi: 10.1001/archsurg.1985.01390300067012.
3
Total dose iron infusion.铁剂输注总量。
Nutr Rev. 1969 Jul;27(7):193-6. doi: 10.1111/j.1753-4887.1969.tb05020.x.
4
Adverse events in chronic hemodialysis patients receiving intravenous iron dextran--a comparison of two products.接受静脉注射右旋糖酐铁的慢性血液透析患者的不良事件——两种产品的比较
Am J Nephrol. 2000 Nov-Dec;20(6):455-62. doi: 10.1159/000046199.
5
Iron-deficiency anemia: a medically treatable chronic anemia as a model for transfusion overuse.缺铁性贫血:一种可通过医学治疗的慢性贫血,作为输血过度使用的一个范例。
Am J Med. 1993 Feb;94(2):120-4. doi: 10.1016/0002-9343(93)90172-l.
6
Parenteral iron therapy in the treatment of iron deficiency anemia during pregnancy: a randomized controlled trial.孕期缺铁性贫血的胃肠外铁剂治疗:一项随机对照试验
J Coll Physicians Surg Pak. 2015 Mar;25(3):193-7.
7
[Intravenous iron-dextran versus peroral iron and blood transfusion for anemia].
Harefuah. 1973 Aug 15;85(4):167-9.
8
[A single infusion of iron dextran in iron deficiency and iron-deficiency anemia].[缺铁及缺铁性贫血中右旋糖酐铁的单次输注]
Nord Med. 1968 Aug 29;80(35):1140-3.
9
Intravenous Imferon masquerading as an acute hemolytic transfusion reaction.伪装成急性溶血性输血反应的静脉注射去铁胺。 (注:这里的Imferon可能有误,推测应该是Desferal即去铁胺,因为去铁胺有静脉注射剂型且与急性溶血性输血反应等医学情况相关,若不是此药名,请根据正确药名准确理解翻译内容)
Transfusion. 1982 Mar-Apr;22(2):163-4. doi: 10.1046/j.1537-2995.1982.22282177129.x.
10
Efficacy and safety of total dose infusion of low molecular weight iron dextran in the treatment of iron deficiency anemia during pregnancy.低分子右旋糖酐铁总剂量输注治疗妊娠期缺铁性贫血的疗效及安全性
J Coll Physicians Surg Pak. 2008 Jul;18(7):424-7.

引用本文的文献

1
Treatment for women with postpartum iron deficiency anaemia.产后缺铁性贫血女性的治疗。
Cochrane Database Syst Rev. 2024 Dec 13;12(12):CD010861. doi: 10.1002/14651858.CD010861.pub3.
2
Treatment for women with postpartum iron deficiency anaemia.产后缺铁性贫血女性的治疗。
Cochrane Database Syst Rev. 2015 Aug 13;2015(8):CD010861. doi: 10.1002/14651858.CD010861.pub2.
3
Anemia in cervical cancer patients: implications for iron supplementation therapy.宫颈癌患者的贫血:铁补充疗法的意义。
Med Oncol. 2005;22(2):161-8. doi: 10.1385/MO:22:2:161.
4
Treatment for women with postpartum iron deficiency anaemia.产后缺铁性贫血女性的治疗。
Cochrane Database Syst Rev. 2004 Oct 18;2004(4):CD004222. doi: 10.1002/14651858.CD004222.pub2.
5
Management of blood loss in Jehovah's Witnesses.耶和华见证人的失血管理。
BMJ. 1995 Oct 28;311(7013):1115-6. doi: 10.1136/bmj.311.7013.1115.